PRECISESADS Clinical Consortium

Latest

• Integrative epigenomics in Sjögren's syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature.
• A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome.
• A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases.
• Genomic Risk Score impact on susceptibility to systemic sclerosis
• Standardization procedure for flow cytometry data harmonization in prospective multicenter studies